In IDH mutant gliomas, neoplastic hypermethylation of transcriptional repressor binding sites leads to the destruction of this binding, resulting in the accumulation of active histone modifications, and finally promote downstream oncogene activation. The gene discussed is IDH1; the disease is central nervous system cancer.